What's in Addrenex Pharmaceuticals, Inc.'s pipeline?

Addrenex Pharmaceuticals, Inc. has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Addrenex Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., Heart Care Foundation, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, Q32 Bio Inc., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/addrenex-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Addrenex Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Addrenex Pharmaceuticals, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
low dose clonidine HCl sustained release	low dose clonidine HCl sustained release	phase 3	Central alpha-2 adrenergic agonist	Alpha-2 adrenergic receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · 1 shared drug class
Heart Care Foundation · 1 shared drug class
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · 1 shared drug class
Q32 Bio Inc. · 1 shared drug class
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Addrenex Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Addrenex Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/addrenex-pharmaceuticals-inc. Accessed 2026-05-16.